European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative

@article{Graeff2019EuropeanCR,
  title={European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative},
  author={N. de Graeff and N. Groot and S. Ozen and D. Eleftheriou and T. Av{\vc}in and B. Bader-Meunier and P. Dole{\vz}alov{\'a} and B. Feldman and I. Kon{\'e}-Paut and P. Lahdenne and L. Mccann and C. Pilkington and A. Ravelli and A. van Royen‐Kerkhof and Y. Uziel and B. Vastert and N. Wulffraat and S. Kamphuis and P. Brogan and M. Beresford},
  journal={Rheumatology},
  year={2019},
  volume={58},
  pages={672–682}
}
OBJECTIVES The European Single Hub and Access point for paediatric Rheumatology in Europe initiative aimed to optimize care for children with rheumatic diseases. [...] Key Method An extensive systematic literature search was performed, and evidence-based recommendations were extrapolated from the included papers. These were evaluated by a panel of international experts via online surveys and subsequently discussed in three consensus meetings, using nominal group technique.Expand
Studying Clinical, Biologic and Echocardiography Criteria to Predict a Resistant Kawasaki Disease in Children
TLDR
This study shows an association between resistant KD and biologic and echocardiography criteria, but only serum sodium is an independent predictive factor. Expand
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
TLDR
The Swiss PIMS-TS recommendations represent best practice guidelines based on currently available knowledge to standardize treatment of children with suspected PIMs-TS. Expand
Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist
TLDR
Significant diagnostic equipoise is observed using a current definition of PIMS-TS, overlapping with KD, and the role of the paediatric rheumatologist is highlighted to contribute to the longer-term MDT follow-up of any late inflammatory sequelae. Expand
Variation in the management of Kawasaki disease
TLDR
The findings highlight the need for international collaborative efforts to optimise management of patients with KD worldwide and the need to assess variation in practice for adjunctive primary treatment of IVIG. Expand
Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view
TLDR
This review aims to draw pediatrician attention to Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease (COVID-19), suggesting early treatment strategies, and proposing a pediatric emergency care flowchart. Expand
Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions
TLDR
There are multiple challenges to PR services in SE ASIA/ASIAPAC countries and there is need for more specialist multidisciplinary services and greater access to medicines and biological therapies. Expand
Overview of Kawasaki Disease in Albaha Area, Saudi Arabia
Background: Kawasaki disease (KD), an acute, febrile, self-limiting vasculitis of unknown etiology, is a disease that predominantly affects mediumand small-sized arteries of infants and preschoolExpand
Lifetime cardiovascular management of patients with previous Kawasaki disease
TLDR
Advice is provided on the long-term management of patients who have vascular complications of KD and guidance on the emergency management of acute coronary complications. Expand
A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis
TLDR
Findings in combination treatment for refractory KD with further understanding of novel genetic risk factors serve as a solid foundation for future research endeavors in the field. Expand
The factors affecting the disease course in Kawasaki disease
TLDR
The risk scoring systems in KD did not predict the risk for IVIG resistance and were not associated with CAI in Turkish population. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 80 REFERENCES
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative
TLDR
Evidence-based recommendations were developed using the European League Against Rheumatism standard operating procedure and it was agreed that new classification criteria for paediatric APS are necessary, and APS in association with childhood-onset systemic lupus erythematosus should be identified by performing antiphospholipid antibody screening. Expand
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative
TLDR
The SHARE recommendations for cSLE and neuropsychiatric manifestations of cSle have been formulated by an evidence-based consensus process to support uniform, high-quality standards of care for children with cSLET. Expand
Consensus-based recommendations for the management of juvenile dermatomyositis
TLDR
Recommendations for the diagnosis and treatment of JDM have been formulated by an evidence-informed consensus process to produce a standard of care for patients with JDM throughout Europe. Expand
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever
TLDR
The objective was to establish recommendations for FMF focusing on provision of diagnostic tools for inexperienced clinicians particularly regarding interpretation of MEFV mutations using the European League against Rheumatism standard operating procedure. Expand
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
TLDR
These recommendations provide updated and best evidence-based guidance to healthcare providers who diagnose and manage Kawasaki disease, but clinical decision making should be individualized to specific patient circumstances. Expand
Recommendations for the management of autoinflammatory diseases
TLDR
These recommendations aim to optimise the management of patients with CAPS, TRAPS and MKD by developing evidence-based recommendations developed using the European League Against Rheumatism standard operating procedure. Expand
Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research
TLDR
A clinical guideline for the diagnosis and treatment of Kawasaki disease in the UK based on the best available evidence to date is proposed, and areas of practice where evidence is anecdotal or based on retrospective data are highlighted. Expand
Failure to Predict High-risk Kawasaki Disease Patients in a Population-based Study Cohort in Germany
TLDR
None of the available scores appears to be appropriate for identifying high-risk Caucasian children with KD who might need intensified therapy, and none was a significant predictor of CAA 1 year after acute illness. Expand
Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015
TLDR
The UK and Ireland incidence of Kawasaki disease has increased and is more frequently seen in winter and rural areas, suggesting earlier and adjunctive primary treatment might reduce complications to prevent CAA, particularly in the very young. Expand
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
TLDR
10 key recommendations for diagnosis of gout were developed using a combination of research based evidence and expert consensus using a Delphi consensus approach. Expand
...
1
2
3
4
5
...